| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |